These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 16925568)

  • 1. Of ends and means.
    Kirk AD; Light JA
    Am J Transplant; 2006 Oct; 6(10):2228-9. PubMed ID: 16925568
    [No Abstract]   [Full Text] [Related]  

  • 2. Tailoring immunosuppressive therapy based on donor and recipient risk factors.
    First MR
    Transplant Proc; 2001 May; 33(3):2207-11. PubMed ID: 11377504
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunosuppression in cardiac transplantation: science, common sense and the heart of the matter.
    Mehra MR; Uber PA; Kaplan B
    Am J Transplant; 2006 Jun; 6(6):1243-5. PubMed ID: 16686745
    [No Abstract]   [Full Text] [Related]  

  • 4. Double-Filtration Plasmapheresis Plus Low-Dose Anti-thymocyte Globulin and Tacrolimus in Asian Living-Donor Kidney Transplantation With Donor-Specific Anti-HLA Antibody.
    Kantachuvesiri S; Ingsathit A; Thammanichanond D; Choochaeam K; Sra-Ium S; Kitiyakara C; Nongnuch A; Sakulchairungrueng B; Worawichawong S
    Transplant Proc; 2021 Apr; 53(3):995-1000. PubMed ID: 32948312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term survival of kidneys transplanted from live A2 donors to O and B recipients.
    Bryan CF; Nelson PW; Shield CF; Warady BA; Winklhofer FT; Murillo D; Wakefield MR
    Am J Transplant; 2007 May; 7(5):1181-4. PubMed ID: 17359511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Steroid-free immunosuppression in kidney transplantation: an editorial review.
    Hricik DE
    Am J Transplant; 2002 Jan; 2(1):19-24. PubMed ID: 12095051
    [No Abstract]   [Full Text] [Related]  

  • 7. Transplantation: new protocols and new worries.
    Grinyo JM
    Saudi J Kidney Dis Transpl; 2009 Mar; 20(2):192-7. PubMed ID: 19237802
    [No Abstract]   [Full Text] [Related]  

  • 8. Mizoribine in combination therapy with tacrolimus for living donor renal transplantation: analysis of a nationwide study in Japan.
    Akiyama T; Okazaki H; Takahashi K; Hasegawa A; Tanabe K; Uchida K; Takahara S; Toma H
    Transplant Proc; 2005 Mar; 37(2):843-5. PubMed ID: 15848551
    [No Abstract]   [Full Text] [Related]  

  • 9. [Kidney transplantation: more kidneys from living donors, individualised immunosuppression and better results].
    van Gelder T; Hesselink DA; Roodnat JI; Ijzermans JN; Weimar W
    Ned Tijdschr Geneeskd; 2003 May; 147(20):955-9. PubMed ID: 12784528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New immunosuppression strategies are needed to improve kidney allograft survival in blacks.
    Tesi RJ; Dagoglou P; Zarifian A; Etheredge EE
    Transplant Proc; 1996 Aug; 28(4):2125-7. PubMed ID: 8769176
    [No Abstract]   [Full Text] [Related]  

  • 11. The use of FK506 in simultaneous pancreas/kidney transplantation: rescue, induction, and maintenance immunosuppression.
    Burke GW; Alejandro R; Ciancio G; Nery J; Roth D; Shapiro R; Scantlebury V; Skyler JS; Ricordi C; Tzakis A
    Transplant Proc; 1995 Dec; 27(6):3123-4. PubMed ID: 8539874
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison between spousal donor transplantation treated with anti-thymocyte globulin induction therapy and, living related donor transplantation treated with standard immunosuppression.
    Demir E; Paydas S; Erken U
    Saudi J Kidney Dis Transpl; 2014 May; 25(3):520-3. PubMed ID: 24821146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alemtuzumab pre-conditioning with tacrolimus monotherapy in pediatric renal transplantation.
    Shapiro R; Ellis D; Tan HP; Moritz ML; Basu A; Vats AN; Kayler LK; Erkan E; McFeaters CG; James G; Grosso MJ; Zeevi A; Gray EA; Marcos A; Starzl TE
    Am J Transplant; 2007 Dec; 7(12):2736-8. PubMed ID: 17908272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mofetil mycophenolate in renal transplantation.
    Pretagostini R; Rossi M; Berloco P; Colonnello M; Bruzzone P; Peritore D; Lonardo MT; Cortesini R
    Transplant Proc; 2001; 33(1-2):1082-3. PubMed ID: 11267200
    [No Abstract]   [Full Text] [Related]  

  • 15. "Not too much, not too little, just right"-Finding the Goldilocks point in pediatric immunosuppression minimization.
    Diamond T; Rand EB
    Liver Transpl; 2024 Jul; 30(7):676-677. PubMed ID: 38270574
    [No Abstract]   [Full Text] [Related]  

  • 16. Limited immune tolerance induced by transient mixed chimerism.
    Yu JH; Chung BH; Oh EJ; Kim JI; Kim HJ; Moon IS; Yang CW
    Korean J Intern Med; 2015 Sep; 30(5):735-8. PubMed ID: 26354070
    [No Abstract]   [Full Text] [Related]  

  • 17. Prevention of complications from use of conventional immunosuppressants: a critical review.
    Ponticelli C; Glassock RJ
    J Nephrol; 2019 Dec; 32(6):851-870. PubMed ID: 30927190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The rocky road of limited immunosuppression for renal transplantation in African Americans.
    Braun WE
    Transplantation; 2007 Feb; 83(3):267-9. PubMed ID: 17297399
    [No Abstract]   [Full Text] [Related]  

  • 19. [Current status and future perspectives of living kidney transplantation from ABO-incompatible or spousal donors].
    Tanabe K
    Nihon Geka Gakkai Zasshi; 2005 Oct; 106(10):659-62. PubMed ID: 16262153
    [No Abstract]   [Full Text] [Related]  

  • 20. Donor bone marrow, chimerism, histocompatibility and renal allograft rejection.
    Ciancio G; Garcia-Morales R; Burke GW; Roth D; Esquenazi V; Tzakis A; Miller J
    Transplant Proc; 1999; 31(1-2):679. PubMed ID: 10083291
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.